300804 广康生化
已收盘 09-22 15:00:00
资讯
新帖
简况
广康生化(300804.SZ)：华拓至盈贰号拟减持39万股公司股份
智通财经 · 09-21 19:40
广康生化(300804.SZ)：华拓至盈贰号拟减持39万股公司股份
广康生化（300804）披露2026年半年度跟踪报告，9月14日股价上涨4.09%
证券之星 · 09-14
广康生化（300804）披露2026年半年度跟踪报告，9月14日股价上涨4.09%
广康生化（300804）披露将参加广东辖区投资者集体接待日暨半年报业绩说明会，9月08日股价上涨0.88%
证券之星 · 09-08
广康生化（300804）披露将参加广东辖区投资者集体接待日暨半年报业绩说明会，9月08日股价上涨0.88%
股市必读：广康生化新发布《关于特定股东减持股份计划期限届满暨实施情况的公告》
证券之星 · 09-07
股市必读：广康生化新发布《关于特定股东减持股份计划期限届满暨实施情况的公告》
9月3日广康生化发布公告，股东减持6万股
证券之星 · 09-03
9月3日广康生化发布公告，股东减持6万股
股市必读：广康生化新发布《2026年半年度报告摘要》
证券之星 · 08-31
股市必读：广康生化新发布《2026年半年度报告摘要》
广康生化（300804）2026年中报简析：净利润同比下降88.6%，三费占比上升明显
证券之星 · 08-29
广康生化（300804）2026年中报简析：净利润同比下降88.6%，三费占比上升明显
广康生化(300804.SZ)：上半年净利润330.67万元 同比下降88.6%
中金财经 · 08-27
广康生化(300804.SZ)：上半年净利润330.67万元 同比下降88.6%
图解广康生化中报：第二季度单季净利润同比下降67.39%
证券之星 · 08-27
图解广康生化中报：第二季度单季净利润同比下降67.39%
广康生化(300804)6月30日股东户数0.63万户，较上期减少16.84%
证券之星 · 08-27
广康生化(300804)6月30日股东户数0.63万户，较上期减少16.84%
广康生化：公司湖北宜昌基地2-硝体车间正在调试阶段
证券之星 · 08-21
广康生化：公司湖北宜昌基地2-硝体车间正在调试阶段
股市必读：广康生化新发布《董事会薪酬与考核委员会关于2026年限制性股票激励计划首次授予激励对象名单（授予日）的核查意见》
证券之星 · 08-12
股市必读：广康生化新发布《董事会薪酬与考核委员会关于2026年限制性股票激励计划首次授予激励对象名单（授予日）的核查意见》
股市必读：广康生化新发布《董事会薪酬与考核委员会关于公司2026年限制性股票激励计划首次授予激励对象名单的公示情况说明及核查意见》
证券之星 · 08-04
股市必读：广康生化新发布《董事会薪酬与考核委员会关于公司2026年限制性股票激励计划首次授予激励对象名单的公示情况说明及核查意见》
广康生化（300804）披露2026年限制性股票激励计划内幕信息知情人买卖公司股票自查报告，8月3日股价下跌2.11%
证券之星 · 08-03
广康生化（300804）披露2026年限制性股票激励计划内幕信息知情人买卖公司股票自查报告，8月3日股价下跌2.11%
股市必读：广康生化（300804）7月28日董秘有最新回复
证券之星 · 07-29
股市必读：广康生化（300804）7月28日董秘有最新回复
广康生化：公司湖北宜昌基地目前仍处于建设阶段
证券之星 · 07-28
广康生化：公司湖北宜昌基地目前仍处于建设阶段
广康生化(300804.SZ)拟推2026年限制性股票激励计划
智通财经 · 07-21
广康生化(300804.SZ)拟推2026年限制性股票激励计划
每周股票复盘：广康生化（300804）每10股派1.50元
证券之星 · 06-21
每周股票复盘：广康生化（300804）每10股派1.50元
股市必读：广康生化（300804）6月15日董秘有最新回复
证券之星 · 06-16
股市必读：广康生化（300804）6月15日董秘有最新回复
广康生化：公司未生产您所提到的高毒农药产品
证券之星 · 06-15
广康生化：公司未生产您所提到的高毒农药产品
暂无数据
公司概况
公司名称：
广东广康生化科技股份有限公司
所属行业：
化学原料和化学制品制造业
上市日期：
2023-06-27
主营业务：
广东广康生化科技股份有限公司的主营业务是农药原药、中间体、制剂的研发、生产和销售。公司的主要产品是联苯肼酯、甲氧虫酰肼等杀虫剂；克菌丹、灭菌丹、噻呋酰胺、土菌灵、萎锈灵等杀菌剂；甜菜宁、甜菜安、乙氧呋草黄等除草剂。公司是国家高新技术企业、国家农药定点生产企业、广东省专精特新中小企业。
发行价格：
42.45
{"stockData":{"symbol":"300804","market":"SZ","secType":"STK","nameCN":"广康生化","latestPrice":44.81,"timestamp":1790060628000,"preClose":46.17,"halted":0,"volume":978658,"delay":0,"changeRate":-0.0295,"floatShares":27500000,"shares":74000000,"eps":0.2028,"marketStatus":"已收盘","change":-1.36,"latestTime":"09-22 15:00:00","open":46.01,"high":46.71,"low":44.35,"amount":44342600,"amplitude":0.0511,"askPrice":45,"askSize":3,"bidPrice":44.81,"bidSize":36,"shortable":0,"etf":0,"ttmEps":0.2028,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790127000000},"marketStatusCode":5,"adr":0,"adjPreClose":46.17,"symbolType":"stock","openAndCloseTimeList":[[1790040600000,1790047800000],[1790053200000,1790060400000]],"highLimit":50.79,"lowLimit":41.55,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":74000000,"isCdr":false,"pbRate":2.51,"roa":"--","peRate":220.956607,"roe":"0.24%","epsLYR":0.55,"committee":0.59633,"marketValue":3316000000,"turnoverRate":0.0356,"status":1,"floatMarketCap":1232000000},"requestUrl":"/m/hq/s/300804/tweets","defaultTab":"tweets","newsList":[{"id":"2669236168","title":"广康生化(300804.SZ)：华拓至盈贰号拟减持39万股公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2669236168","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669236168?lang=zh_cn&edition=full","pubTime":"2026-09-21 19:40","pubTimestamp":1789990811,"startTime":"0","endTime":"0","summary":"智通财经APP讯，广康生化(300804.SZ)发布公告，持有公司股份39万股(占公司总股本0.527%)的特定股东共青城华拓至盈贰号投资合伙企业(有限合伙)(简称“华拓至盈贰号”)计划在公告披露之日起三个交易日后的三个月内以集中竞价交易或大宗交易减持公司股份39万股(占公司总股本比例0.527%)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1498921.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"广康生化(300804.SZ)：华拓至盈贰号拟减持39万股公司股份","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0229","300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667953652","title":"广康生化（300804）披露2026年半年度跟踪报告，9月14日股价上涨4.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667953652","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667953652?lang=zh_cn&edition=full","pubTime":"2026-09-14 17:44","pubTimestamp":1789379080,"startTime":"0","endTime":"0","summary":"截至2026年9月14日收盘，广康生化报收于42.29元，较前一交易日上涨4.09%，最新总市值为31.29亿元。近日，华泰联合证券有限责任公司发布《关于广东广康生化科技股份有限公司2026年半年度跟踪报告》。保荐人每月查看募集资金专户，列席股东会和董事会各一次，发表专项意见5次。公司归母净利润同比下降88.60%，主要受产能利用率低、原材料价格上涨及客户采购模式变化影响，保荐人已提请公司关注风险并采取应对措施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400023821.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665211053","title":"广康生化（300804）披露将参加广东辖区投资者集体接待日暨半年报业绩说明会，9月08日股价上涨0.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665211053","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665211053?lang=zh_cn&edition=full","pubTime":"2026-09-08 18:05","pubTimestamp":1788861957,"startTime":"0","endTime":"0","summary":"截至2026年9月8日收盘，广康生化报收于45.65元，较前一交易日上涨0.88%，最新总市值为33.78亿元。该股当日开盘45.25元，最高46.48元，最低44.8元，成交额达3970.01万元，换手率为3.16%。广康生化于近日披露《关于参加2026年广东辖区投资者集体接待日暨辖区上市公司半年报业绩说明会活动的公告》。公司董事长兼总经理蔡丹群、董事会秘书兼财务总监陈海霞将就公司2026年半年度业绩、公司治理、发展战略及经营状况等与投资者进行在线交流。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800028750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665362043","title":"股市必读：广康生化新发布《关于特定股东减持股份计划期限届满暨实施情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2665362043","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665362043?lang=zh_cn&edition=full","pubTime":"2026-09-07 01:27","pubTimestamp":1788715628,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，广康生化报收于45.08元，下跌1.68%，换手率3.28%，成交量9007.0手，成交额4121.91万元。当日关注点交易信息汇总：9月4日主力资金净流出146.2万元，占总成交额3.55%。公司公告汇总关于特定股东减持股份计划期限届满暨实施情况的公告广东广康生化科技股份有限公司特定股东减持计划已届满：华拓至远叁号减持60,000股，占总股本0.0811%，减持均价39.73元/股；华拓至盈贰号未减持。本次减持未导致公司控制权变更，不影响公司治理结构及持续经营。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700000732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664879819","title":"9月3日广康生化发布公告，股东减持6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664879819","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664879819?lang=zh_cn&edition=full","pubTime":"2026-09-03 19:01","pubTimestamp":1788433284,"startTime":"0","endTime":"0","summary":"证券之星消息，9月3日广康生化发布公告《广康生化:关于特定股东减持股份计划期限届满暨实施情况的公告》，其股东深圳市华拓至远叁号投资企业(有限合伙)于2026年7月30日合计减持6.0万股，占公司目前总股本的0.0811%，变动期间该股股价上涨8.29%，截止7月30日收盘报39.97元。股东增减持详情见下表：根据广康生化2026年中报公布的十大股东详情如下：本文数据来源于广康生化公告，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300036074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663902866","title":"股市必读：广康生化新发布《2026年半年度报告摘要》","url":"https://stock-news.laohu8.com/highlight/detail?id=2663902866","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663902866?lang=zh_cn&edition=full","pubTime":"2026-08-31 07:58","pubTimestamp":1788134292,"startTime":"0","endTime":"0","summary":"公司公告汇总：2026年半年度报告显示净利润同比下降88.60%，经营活动现金流量净额为-7345.00万元，同比减少289.92%。公司公告汇总：公司拟继续开展总额度不超过5,000万美元的外汇衍生品交易业务，授权期自2026年9月23日起12个月内有效。公司公告汇总：截至2026年6月30日，募集资金余额为250,684,256.86元；报告期内投入10,632.30万元，累计投入35,040.79万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100002006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016248","title":"广康生化（300804）2026年中报简析：净利润同比下降88.6%，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016248","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663016248?lang=zh_cn&edition=full","pubTime":"2026-08-29 06:48","pubTimestamp":1787957338,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期广康生化发布2026年中报。截至本报告期末，公司营业总收入3.82亿元，同比下降4.19%，归母净利润330.67万元，同比下降88.6%。本报告期广康生化三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达31.27%。去年的净利率为5.35%，算上全部成本后，公司产品或服务的附加值一般。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900013058.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662086198","title":"广康生化(300804.SZ)：上半年净利润330.67万元 同比下降88.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662086198","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662086198?lang=zh_cn&edition=full","pubTime":"2026-08-27 22:37","pubTimestamp":1787841422,"startTime":"0","endTime":"0","summary":"格隆汇8月27日丨广康生化(300804.SZ)公布半年度报告，报告期内，公司实现营业收入38,221.11万元，较上年同期下降4.19%；实现归属于上市公司股东的净利润330.67万元，较上年同期下降88.60%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260827/32350735.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662709741","title":"图解广康生化中报：第二季度单季净利润同比下降67.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662709741","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662709741?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:02","pubTimestamp":1787828565,"startTime":"0","endTime":"0","summary":"证券之星消息，广康生化2026年中报显示，上半年度公司主营收入3.82亿元，同比下降4.19%；归母净利润330.67万元，同比下降88.6%；扣非净利润280.42万元，同比下降89.8%；其中2026年第二季度，公司单季度主营收入2.22亿元，同比上升4.77%；单季度归母净利润388.22万元，同比下降67.39%；单季度扣非净利润417.91万元，同比下降66.99%；负债率38.61%，投资收益165.7万元，财务费用1108.24万元，毛利率21.03%。财报数据概要请见下图:本文数据来源于广康生化2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700045198.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703261","title":"广康生化(300804)6月30日股东户数0.63万户，较上期减少16.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703261","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662703261?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:15","pubTimestamp":1787825750,"startTime":"0","endTime":"0","summary":"证券之星消息，近日广康生化披露，截至2026年6月30日公司股东户数为6263.0户，较3月31日减少1268.0户，减幅为16.84%。在农化制品行业个股中，广康生化股东户数低于行业平均水平，截至6月30日，农化制品行业平均股东户数为4.91万户。从股价来看，2026年3月31日至2026年6月30日，广康生化区间跌幅为31.45%，在此期间股东户数减少1268.0户，减幅为16.84%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700043792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661255592","title":"广康生化：公司湖北宜昌基地2-硝体车间正在调试阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2661255592","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661255592?lang=zh_cn&edition=full","pubTime":"2026-08-21 09:01","pubTimestamp":1787274070,"startTime":"0","endTime":"0","summary":"证券之星消息，广康生化(300804)08月20日在投资者关系平台上答复投资者关心的问题。投资者提问：老师，你好！湖北宜昌基地年产25456吨特种新材料建设项目的2-硝体车间，是否已完成建设进入试车，是否已完成单机调试等工作？广康生化回复：尊敬的投资者，您好！公司湖北宜昌基地2-硝体车间正在调试阶段。后续进展敬请关注公司公告。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100009310.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658917141","title":"股市必读：广康生化新发布《董事会薪酬与考核委员会关于2026年限制性股票激励计划首次授予激励对象名单（授予日）的核查意见》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658917141","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658917141?lang=zh_cn&edition=full","pubTime":"2026-08-12 02:15","pubTimestamp":1786472113,"startTime":"0","endTime":"0","summary":"第四届董事会第七次会议决议公告公司于2026年8月10日召开第四届董事会第七次会议，审议通过《关于向2026年限制性股票激励计划激励对象首次授予限制性股票的议案》，确定授予日为2026年8月10日，向18名激励对象授予96.00万股限制性股票，授予价格为16.24元/股；关联董事蔡丹群、林硕回避表决；会议同时审议通过《关于选举吴光辉先生为公司第四届董事会战略委员会委员的议案》，选举吴光辉为战略委员会委员，任期至第四届董事会任期届满。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200002112.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656064573","title":"股市必读：广康生化新发布《董事会薪酬与考核委员会关于公司2026年限制性股票激励计划首次授予激励对象名单的公示情况说明及核查意见》","url":"https://stock-news.laohu8.com/highlight/detail?id=2656064573","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656064573?lang=zh_cn&edition=full","pubTime":"2026-08-04 02:36","pubTimestamp":1785782173,"startTime":"0","endTime":"0","summary":"公司公告汇总董事会薪酬与考核委员会关于公司2026年限制性股票激励计划首次授予激励对象名单的公示情况说明及核查意见广东广康生化科技股份有限公司于2026年7月22日至7月31日对公司2026年限制性股票激励计划首次授予激励对象名单进行了内部公示，公示期间未收到异议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400001843.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656370333","title":"广康生化（300804）披露2026年限制性股票激励计划内幕信息知情人买卖公司股票自查报告，8月3日股价下跌2.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656370333","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656370333?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:52","pubTimestamp":1785768732,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘，广康生化报收于38.0元，较前一交易日下跌2.11%，最新总市值为28.12亿元。公告显示，公司对2026年限制性股票激励计划内幕信息知情人在2026年1月21日至7月21日期间买卖公司股票情况进行了自查。其余核查对象无买卖行为。公司已采取必要保密措施，未发现内幕信息泄露或利用内幕信息交易的情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300037906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655811348","title":"股市必读：广康生化（300804）7月28日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2655811348","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655811348?lang=zh_cn&edition=full","pubTime":"2026-07-29 01:34","pubTimestamp":1785260053,"startTime":"0","endTime":"0","summary":"截至2026年7月28日收盘，广康生化报收于37.01元，上涨3.15%，换手率7.96%，成交量2.19万手，成交额8080.59万元。董秘最新回复投资者： 老师，您好！请问公司宜昌基地年产25458吨特种新材料建设项目进展如何？公司湖北宜昌基地目前仍处于建设阶段，部分车间进入调试阶段。当日关注点交易信息汇总：7月28日主力资金净流入442.5万元，游资资金净流入147.09万元，散户资金净流出589.58万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900001138.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654072606","title":"广康生化：公司湖北宜昌基地目前仍处于建设阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2654072606","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654072606?lang=zh_cn&edition=full","pubTime":"2026-07-28 16:24","pubTimestamp":1785227092,"startTime":"0","endTime":"0","summary":"证券之星消息，广康生化(300804)07月28日在投资者关系平台上答复投资者关心的问题。投资者提问：老师，您好！请问公司宜昌基地年产25458吨特种新材料建设项目进展如何？谢谢！广康生化回复：尊敬的投资者，您好！公司湖北宜昌基地目前仍处于建设阶段，部分车间进入调试阶段。后续进展敬请关注公司公告。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800025747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653272661","title":"广康生化(300804.SZ)拟推2026年限制性股票激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2653272661","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653272661?lang=zh_cn&edition=full","pubTime":"2026-07-21 19:56","pubTimestamp":1784635012,"startTime":"0","endTime":"0","summary":"智通财经APP讯，广康生化(300804.SZ)发布2026年限制性股票激励计划(草案)，本激励计划拟向激励对象授予限制性股票120.00万股，约占本激励计划草案公告时公司总股本1.62%。其中，首次授予限制性股票96.00万股，预留限制性股票24.00万股。授予价格为16.24元/股。本激励计划有效期自限制性股票授予之日起至激励对象获授的限制性股票全部归属或作废失效之日止，最长不超过60个月。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1470519.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645209672","title":"每周股票复盘：广康生化（300804）每10股派1.50元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645209672","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645209672?lang=zh_cn&edition=full","pubTime":"2026-06-21 03:35","pubTimestamp":1781984112,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，广康生化报收于36.43元，较上周的38.04元下跌4.23%。本周，广康生化6月15日盘中最高价报39.5元。广康生化当前最新总市值26.96亿元，在农化制品板块市值排名47/58，在两市A股市值排名4576/5206。本次权益分派股权登记日为2026年6月24日，除权除息日为2026年6月25日。本次实施的方案与股东会审议通过的一致，且股本总额在实施前未发生变化。权益分派实施后，相关股东及董监高的最低减持价格将调整为41.63元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100001207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643078316","title":"股市必读：广康生化（300804）6月15日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2643078316","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643078316?lang=zh_cn&edition=full","pubTime":"2026-06-16 03:30","pubTimestamp":1781551832,"startTime":"0","endTime":"0","summary":"截至2026年6月15日收盘，广康生化报收于37.53元，下跌1.34%，换手率5.73%，成交量1.58万手，成交额6031.45万元。董秘最新回复投资者： 6月1日，氧乐果、克百威、灭多威、涕灭威4种高毒农药全面禁止销售和使用。关于氯虫苯甲酰胺，公司目前也未生产该产品。当日关注点交易信息汇总：6月15日主力资金净流出69.06万元，游资资金净流出393.77万元，散户资金净流入462.82万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600004454.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643827537","title":"广康生化：公司未生产您所提到的高毒农药产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2643827537","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643827537?lang=zh_cn&edition=full","pubTime":"2026-06-15 15:51","pubTimestamp":1781509874,"startTime":"0","endTime":"0","summary":"证券之星消息，广康生化(300804)06月15日在投资者关系平台上答复投资者关心的问题。投资者提问：6月1日，氧乐果、克百威、灭多威、涕灭威4种高毒农药全面禁止销售和使用。至此，加上2024年9月已退市的甲拌磷、甲基异柳磷、水胺硫磷、灭线磷，两年间已有8种高毒农药彻底告别市场，全国禁用农药品种达到约60种。请问上述产品禁用对公司生产、经营有没有影响？氯虫苯甲酰胺能不能替代上述产品？广康生化回复：您好，公司未生产您所提到的高毒农药产品，相关禁用政策对公司生产、经营没有影响。关于氯虫苯甲酰胺，公司目前也未生产该产品。谢谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061500015571.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790076633515,"stockEarnings":[{"period":"1week","weight":0.0917},{"period":"1month","weight":0.07},{"period":"3month","weight":0.2845},{"period":"6month","weight":0.0329},{"period":"1year","weight":0.1944},{"period":"ytd","weight":0.3248}],"compareEarnings":[{"period":"1week","weight":0.0166},{"period":"1month","weight":0.0114},{"period":"3month","weight":-0.0381},{"period":"6month","weight":0.0046},{"period":"1year","weight":0.034},{"period":"ytd","weight":-0.0048}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广东广康生化科技股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"6263人(较上一季度减少16.84%)","perCapita":"4390股","listingDate":"2023-06-27","address":"广东省清远市英德市农用化工产业链专用基地(英德市沙口镇红丰管理区)","registeredCapital":"7400万元","survey":" 广东广康生化科技股份有限公司的主营业务是农药原药、中间体、制剂的研发、生产和销售。公司的主要产品是联苯肼酯、甲氧虫酰肼等杀虫剂；克菌丹、灭菌丹、噻呋酰胺、土菌灵、萎锈灵等杀菌剂；甜菜宁、甜菜安、乙氧呋草黄等除草剂。公司是国家高新技术企业、国家农药定点生产企业、广东省专精特新中小企业。","listedPrice":42.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"广康生化(300804)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供广康生化(300804)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"广康生化,300804,广康生化股票,广康生化股票老虎,广康生化股票老虎国际,广康生化行情,广康生化股票行情,广康生化股价,广康生化股市,广康生化股票价格,广康生化股票交易,广康生化股票购买,广康生化股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"广康生化(300804)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供广康生化(300804)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}